Gene and cell therapy is moving fast – and in a clear direction. Programs are pushing toward more complex payloads, virus-free engineering, and manufacturing models that can scale from early research ...

New England Biolabs (NEB®) today announced the release of the EnClose Cell-free dbDNA Synthesis Kit, developed in ...

Touchlight, in collaboration with New England Biolabs (NEB®), announces the launch of the EnClose™ Cell-free dbDNA™ Synthesis Kit, a new benchtop solution enabling rapid enzymatic production of ...

Apertura Gene Therapy, a biotechnology company developing next-generation AAV capsids for delivering genetic medicines, and ...

Following through with its sizable investment commitment in China, AstraZeneca on Thursday unveiled plans to build a ...

Multinationals are building self-reliant supply chains in China to insulate local markets from potential trade disruptions, ...

The CBSE Class 12 Biology exam 2026 is scheduled for March 27, Friday. Experts emphasize that conceptual understanding, ...

A judge recently ruled that HHS Secretary Robert F. Kennedy Jr. went too far in his drive to turn ACIP into a an antivax ...

Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing ...

Viral Vector Manufacturing Facility Pty Ltd (VVMF), Australia’s first commercial viral vector Contract Development and ...

This fundamental work uncovers an unexpected lysosomal function for NINJ2 and links it to ferroptosis and cancer biology. The evidence supporting the conclusions appears to be convincing. Additional ...